Seatrack International is a manufacturer and supplier of pharmaceutical products in the front line and is backed by financial companies and private investment banks under one group to fulfill requirements for certain pharmaceutical R&D projects, as well as construction and research facilities development.

The company has obtained license with CDSCO, the Central Drugs Standard Control Organization is the Indian regulatory body for pharmaceuticals and medical devices, being the equivalent of the FDA in the US.

The Group has relevant import and distribution license for its products to European countries through the Budapest, Hungary office.

Seatrack International Group is working closely with Health Ministries for production and supply of certain medicines, especially medicines related to the current Corona virus outbreak.

Seatrack International has labs specialized in infections& diseases R&D for the purpose of projects based on certain research requirements stipulated by relevant department of Health Ministry. We have multiple R&D centers equipped with cutting-edge enabling technologies. Our scientists have expertise in developing generics, Active Pharmaceutical Ingredients (APIs), Novel Drug Delivery Systems (NDDS) and New Chemical Entities (NCEs).


Our capabilities span the development of differentiated products, such as liposomal products, inhalers, lyophilized injections, nasal sprays, besides developing controlled release dosage forms.

In Synergy

Our scientists work closely with our business development team to generate innovative concepts and ideas, exploiting both market needs and synergies across therapeutic areas.


Indian pharmaceutical industry has witnessed drastic changes in recent years.Companies have realized that it is important to evolve new business models that should fit within their research & business scheme. Dependability on reverse engineering alone will not provide durability.

With robust R&D activity, it was indicated that the R&D spending of the Indian pharmaceutical industry will reach about 8%-9%. Various Indian Pharma companies have initiated drug discovery as one of the major focus area. Pharmaceutical industry has realized that long term success can be ensured through novel drug discovery and innovations.



Indian pharmaceutical industry is in continuous search to discover and develop new drugs targeted toward complex diseases. This has resulted in a situation that Pharmaceutical industry must use innovative technologies that will help to ramp up research and development along with provide manufacturing and analytical capabilities.

At Seatrack International Group R&D facilities, adopting new technologies is of utmost importance. Innovation in technologies have enabled access to a wide range of software and cloud based solutions. This in turn has simplified compound identification, quantification and complex data analysis.